Stat One

Executive Summary

Stat One is a US-based Contract Research Organization (CRO) founded in 2017, specializing in statistical consulting and eClinical solutions for pharmaceutical, biotechnology, medical device, and diagnostic companies. The company’s core asset is its proprietary Stat One EDC® system, an electronic data capture platform designed to simplify clinical trial data management and study execution. Operating at the intersection of digital health and AI/ML, Stat One positions itself as a nimble alternative to larger CROs, offering scalable and efficient data management services. Despite its niche focus, the company remains relatively small and private, with no disclosed funding rounds or valuation, limiting its visibility in a competitive market. However, its specialization in statistical consulting and its EDC platform could appeal to sponsors seeking cost-effective, streamlined trial operations. The company’s growth trajectory will depend on its ability to secure high-value client contracts and differentiate its platform amid crowded competition from established CROs and eClinical vendors.

Upcoming Catalysts (preview)

• Q3 2026New major client contract or partnership with a top pharma or biotech30% success
• Q2 2026Significant platform update or AI/ML feature integration for Stat One EDC®50% success
• Q4 2026Regulatory submission or approval for a pivotal trial using Stat One EDC®20% success